Associations between BODE index and systemic inflammatory biomarkers in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 6, 2011, Pages 408-413

  Gaki, Eleni ^a   Kontogianni, Konstantina ^a   Papaioannou, Andriana I ^b   Bakakos, Petros ^a   Gourgoulianis, Konstantinos I ^b   Kostikas, Konstantinos ^a,b   Alchanatis, Manos ^a   Papiris, Spyridon ^a   Loukides, Stelios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Adipose tissue; COPD; CRP; Cytokines; FFMI; Nutrition

Indexed keywords

ADIPONECTIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 6; LEPTIN; LONG ACTING BETA 2 AGONIST; SHORT ACTING BETA 2 AGONIST; THEOPHYLLINE; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODE INDEX; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FAT FREE MASS INDEX; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN THERAPY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83155191784     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.619599     Document Type: Article

References (33)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
2. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012. (Pubitemid 38269277)
3. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc 2003; 62:783-791. (Pubitemid 38004973)
4. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26:703-719. (Pubitemid 41448671)
5. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl 2003; 46:81s-86s. (Pubitemid 37351740)
6. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007; 8:25.
7. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132:164-169. (Pubitemid 47068217)
8. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53-59. (Pubitemid 41716377)
9. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79-83. (Pubitemid 43069791)
10. Barnes PJ, Celli BR. Systemic manifestations and co-morbidities of COPD. Eur Respir J 2009; 33:1165-1185.
11. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19:547-566. (Pubitemid 41823815)
12. Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. RespirMed 2010; 104:275-282.
13. Krommidas G, Kostikas K, Papatheodorou G, Koutsokera A, Gourgoulianis KI, Roussos C, et al. Plasma leptin and adiponectin inCOPD exacerbations: associations with inflammatory biomarkers. Respir Med 2010; 104:40-46.
14. Tomoda K, Yoshikawa M, Itoh T, Tamaki S, Fukuoka A, Komeda K, et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 2007; 132:135-140. (Pubitemid 47068213)
15. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174:867-874. (Pubitemid 44564786)
16. Charlson ME, Pompei P, Ales KL,MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383. (Pubitemid 17055592)
17. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure co-morbidity. a critical review of available methods. J Clin Epidemiol 2003; 56:221-229. (Pubitemid 36513483)
18. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41:810-817. (Pubitemid 15092891)
19. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA. Height-normalized indices of the bodys fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52:953-959. (Pubitemid 120008197)
20. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136.
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of theMedical Research Council (MRC) dyspnoea scale asameasure of disability inpatientswith chronic obstructive pulmonary disease.Thorax 1999; 54:581-586. (Pubitemid 29296676)
22. ATS. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117.
23. AgustiAG, NogueraA, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21:347-360. (Pubitemid 36204553)
24. Erselcan T, Candan F, Saruhan S, Ayca T. Comparison of body composition analysismethods in clinical routine. AnnNutrMetab 2000; 44:243-248. (Pubitemid 32037548)
25. Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:1215-1219. (Pubitemid 29202558)
26. Schols AM, Creutzberg EC, Buurman WA, Campfield LA, Saris WH,Wouters EF. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit CareMed 1999; 160:1220-1226. (Pubitemid 29487462)
27. Steiner AA, Romanovsky AA. Leptin: at the crossroads of energy balance and systemic inflammation. Prog Lipid Res 2007; 46:89-107. (Pubitemid 46654230)
28. Yende S, WatererGW, Tolley EA,Newman AB, BauerDC, Taaffe DR, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.Thorax 2006; 61:10-16. (Pubitemid 43106971)
29. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.AmJ Respir Crit CareMed 1996; 153:633-637.
30. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM. Raised CRP levels mark metabolic and functional impairment in advanced COPD.Thorax 2006; 61:17-22. (Pubitemid 43106972)
31. Eagan TM, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, et al. Body composition and plasma levels of inflammatory biomarkers in COPD. Eur Respir J. 2010; 36(5):1027-1033.
32. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:760-765. (Pubitemid 39298991)
33. LeeMJ,Wang Y, Ricci MR, Sullivan S, Russell CD, Fried SK.Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. Am J Physiol Endocrinol Metab 2007; 292:E858-864. (Pubitemid 46411065)